Skip to content

Effect of low carbohydrate food products on diabetics

A pilot study to evaluate the efficacy and safety of low carb DiabeSmart Batter Premix, Bhujia, & Premix atta in preventing hyperglycemia in comparison with standard carb diet among diabetics and pre diabetics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046931
Enrollment
60
Registered
2022-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Test Product 1 - DiabeSmart Batter Premix (Low carb Dosa or Idli). 2. DiabeSmart Low carb Bhujia 3. Diabesmart premix atta â?? Roti : DAY 2: Test Product 1 Once at 0.25 Hours Test Pro

Sponsors

Bajo Foods Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects with history of prediabetes (5.7-6.4%) and Diabetes mellitus â?? type II for 1-15 years. 2. Diabetics with Hba1c >7.5%

Exclusion criteria

Exclusion criteria: 1. History of hypersensitivity to any of the study treatments, excipients, or drugs of similar chemical classes including sulfonylureas and meglitinides 2. History of type 1 diabetes 3. Subjects on insulin therapy 4. Subjects with the history of uncontrolled hypertension and/or hyperthyroidism 5. History of alcoholism 6. Subjects with psychiatric or neurological disability or mental health disorder 7. Subjects with serious health conditions such as cardiac disease, renal dysfunction, and cancers. 8. Female subjects who are pregnant or had planned for pregnancy in the following months or were breast feeding. 9. Subjects who refuse to sign informed consent 10. Those who have participated in another clinical trial within 1 month of visit 1 or plan to participate during the clinical trial period. 11. According to the investigatorâ??s opinion, participants who are deemed unable to comply with the test requirements or otherwise deemed unsuitable 12. Any planned surgery during study.

Design outcomes

Primary

MeasureTime frame
1. Fasting Blood Sugar Test 2. Post-prandial blood glucoseTimepoint: 1. Day 1 and Day 2: at 8:00 AM 2. Day 1 and Day 2: After 1 hr. and after 2 hrs. of reference or test product consumption

Secondary

MeasureTime frame
Occurrence of AETimepoint: Throughout the study

Countries

India

Contacts

Public ContactSubham Dutta

Bajo Foods Pvt Ltd

sudarshan@bajofoods.com9606600927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026